Solidion Technology (NASDAQ: STI) sieht keinen Grund, sein Angebot an Polar Power, Inc. (NASDAQ: POLA) als Reaktion auf die Ablehnung des Vorschlags zur Übernahme der Vermögenswerte gegen Barzahlung durch den Vorstand zu erhöhen

Solidion said it will not raise its cash proposal to acquire substantially all of Polar Power’s assets after Polar’s board rejected it. Solidion cited Polar’s $2.0 million net loss and $2.2 million operating cash burn in the six months ended June 30, 2026, leaving $183,000 in cash, as well as financing needs, Nasdaq compliance issues, and substantial doubt about continued operations. The proposal is nonbinding, and no transaction is assured; Polar has until October 28, 2026, to demonstrate Nasdaq compliance.

Analysis

POLA’s key risk is not simply whether Solidion returns with a higher bid; it is that the rejected proposal leaves shareholders exposed to a financing clock while the company retains the operating and execution risk. A discounted, market-linked conversion can create a reflexive dilution loop: weak trading increases the share count needed to raise capital, which can further pressure the stock and negotiating leverage. The near-term Nasdaq compliance date is therefore a catalyst, but a technical cure would not by itself resolve the working-capital problem.

Treat Solidion’s description of POLA as distressed as an interested buyer’s negotiating position, not independent diligence. Conversely, its refusal to raise the bid limits the immediate value of deal optionality. A renewed asset sale could still emerge at revised terms, but investors should not price it as a committed floor; asset transfers may also leave shareholders with a diminished operating company and unresolved financing needs.

For STI, the announcement offers little evidence of material strategic or financial benefit: any acquisition remains conditional, and disciplined pricing could mean no transaction. Do not infer battery-business synergies or earnings accretion without disclosed asset scope, funding, and integration economics. Near term, POLA financing and Nasdaq developments dominate; over 1–3 months, watch for compliance evidence, new capital terms, or renewed negotiations. Over 6–18 months, value depends on whether POLA can fund operations and whether a buyer can realize asset value. The contrarian risk is that a compliance cure or financing on less punitive terms could trigger a sharp relief rally from distressed expectations.

Key Decisions for Investors

• POLA: Avoid treating the rejected offer as a valuation floor. Until the company demonstrates operating liquidity beyond a technical Nasdaq cure, keep exposure small or avoid; any short is conditional on borrow availability and liquidity, given squeeze and microcap execution risk.
• Watch the October 28 Nasdaq compliance deadline and subsequent filings for actual equity compliance, cash runway, and financing terms. A new discounted or variable-price instrument, or evidence that operating cash needs exceed available funding, would strengthen the downside thesis; a funded runway on materially less dilutive terms would falsify it.
• STI: No direct trade from this announcement alone. Reassess only if a definitive agreement discloses purchase price, assets and liabilities assumed, funding source, and expected contribution; walk-away discipline is not itself an earnings catalyst.
• Do not use STI as a hedge for POLA: the companies have distinct operating and financing risks, and the proposed transaction is not binding. Track POLA’s price reaction alongside share issuance and compliance disclosures rather than headline sentiment.